Literature DB >> 2841716

Hepatocellular carcinoma and cavernous hemangioma: differentiation with MR imaging. Efficacy of T2 values at 0.35 and 1.5 T.

K Ohtomo1, Y Itai, K Yoshikawa, T Kokubo, M Iio.   

Abstract

Seventy-two patients with hepatocellular carcinoma (hepatoma) and 56 with hemangioma were studied with magnetic resonance (MR) imaging at 0.35 or 1.5 T to evaluate the efficacy of T2 values in differential diagnosis. T2 values were calculated with the two-point method. The mean T2 values of hepatoma and hemangioma were 58.9 msec +/- 8.9 and 101.6 msec +/- 25.8 at 0.35 T and 49.1 msec +/- 9.8 and 85.3 msec +/- 21.2 at 1.5 T. The difference in the T2 values for hepatoma and hemangioma was statistically significant (P less than .001) at both 0.35 and 1.5 T. Fifty-three of 56 lesions (94.6%) at 0.35 T and 86 of 102 lesions (84.3%) at 1.5 T were correctly classified when the T2 borderline between hepatoma and hemangioma was set at 80 msec. All misdiagnosed lesions were hemangioma, and all but one were smaller than 2 cm. However, over 90% of lesions smaller than 2 cm were correctly diagnosed when 70 msec at 0.35 T and 60 msec at 1.5 T were used as borderline T2 values. MR imaging with T2 measurement was very useful for differentiating between hepatoma and hemangioma (including small lesions) at 1.5 T as well as at 0.35 T.

Entities:  

Mesh:

Year:  1988        PMID: 2841716     DOI: 10.1148/radiology.168.3.2841716

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  8 in total

1.  Improved short tau inversion recovery (iSTIR) for increased tumor conspicuity in the abdomen.

Authors:  Ananth J Madhuranthakam; Karen S Lee; Aya Yassin; Jean H Brittain; Ivan Pedrosa; Neil M Rofsky; David C Alsop
Journal:  MAGMA       Date:  2013-09-20       Impact factor: 2.310

2.  Characterization of focal liver lesions using quantitative techniques: comparison of apparent diffusion coefficient values and T2 relaxation times.

Authors:  Andrzej Cieszanowski; Agnieszka Anysz-Grodzicka; Wojciech Szeszkowski; Bartosz Kaczynski; Edyta Maj; Barbara Gornicka; Mariusz Grodzicki; Ireneusz P Grudzinski; Anna Stadnik; Marek Krawczyk; Olgierd Rowinski
Journal:  Eur Radiol       Date:  2012-06-15       Impact factor: 5.315

3.  MR imaging of malignant mesenchymal tumors of the liver.

Authors:  K Ohtomo; T Araki; Y Itai; S Monzawa; H Ohba; Y Nogata; T Hihara; K Koizumi; G Uchiyama
Journal:  Gastrointest Radiol       Date:  1992

4.  MR findings of hepatic cavernous hemangioma after intraarterial infusion of iodized oil.

Authors:  B I Choi; Y M Shin; J W Chung; S H Kim; J H Park; M C Han
Journal:  Abdom Imaging       Date:  1994 Nov-Dec

5.  Breathhold multiecho fast spin-echo pulse sequence for accurate R2 measurement in the heart and liver.

Authors:  Daniel Kim; Jens H Jensen; Ed X Wu; Sujit S Sheth; Gary M Brittenham
Journal:  Magn Reson Med       Date:  2009-08       Impact factor: 4.668

Review 6.  Resolving genetic heterogeneity in cancer.

Authors:  Samra Turajlic; Andrea Sottoriva; Trevor Graham; Charles Swanton
Journal:  Nat Rev Genet       Date:  2019-07       Impact factor: 53.242

Review 7.  Distinguishing benign from malignant liver tumours.

Authors:  Jay P Heiken
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

8.  Defining the Modalities of Intravenous Contrast Application During the Diagnostics of Hepatic Metastases with Computerized Tomography.

Authors:  Arben Kutllovci; Halit Ymeri; Drita Zogaj; Skender Kutllovci; Dukagjin Zogaj
Journal:  Acta Inform Med       Date:  2016-02-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.